DNA甲基转移酶在肝门部胆管癌中的表达及临床意义

Expression of DNA methyltransferases in hilar cholangiocarcinoma and its clinical significance

  • 摘要: 目的 探讨 DNA甲基转移酶(DNMTs)在肝门部胆管癌中的表达及其临床意义。方法 收集 1997年4月至2007年3月中山大学附属第一医院收治的 111例肝门部胆管癌患者(胆管癌组)和 39例胆总管囊肿患者(对照组)胆管组织标本,构建组织芯片,采用免疫组织化学方法检测 DNMT1、DNMT3a、 DNMT3b的蛋白表达水平;比较胆管癌组与对照组的胆管组织中 DNMTs蛋白表达的差异;分析肝门部胆管癌组织中 DNMTs蛋白表达与临床病理因素的关系,计数资料的比较采用 χ 2 检验或 Fisher确切概率法, KaplanMeier法绘制生存曲线,生存情况分析采用 Logrank检验。结果 胆管癌组的 DNMT1和 DNMT3b 高表达率分别为54.1%(60/111)和47.7%(53/111),显著高于对照组的28.2%(11/39)和23.1%(9/39), 两组比较,差异有统计学意义(χ 2 =7.740,7.240,P<0.05)。DNMT1的高表达与 BismuthCorlette分型、 T分期存在明显相关性(χ 2 =12.200,17.800,P<0.05);而 DNMT3a在胆管癌组和对照组的高表达率比较,差异无统计学意义(χ 2 =3.370,P>0.05);DNMT3b的高表达则只与 BismuthCorlette分型存在明显相关性(χ 2 =8.300,P<0.05)。111例患者中66例行肝门部胆管癌切除术,其中42例获得随访。DNMT1低表达者的术后中位生存时间为23.9个月,明显长于 DNMT1高表达者的11.8个月(χ 2 =3.980,P<0.05)。结论 DNMT1和 DNMT3b高表达在肝门部胆管癌发生、发展中起重要作用;DNMT1的表达水平与肝门部胆管癌根治性切除术后生存时间明显相关,可望成为有价值的预测因子。

     

    Abstract: Objective To investigate the expression of DNA methyltransferases (DNMTs) in hilar cholangiocarcinoma and its clinical significance. Methods A total of 150 samples of cholangetic tissues were collected from 111 patients with hilar cholangiocarcinoma (cholangiocarcinoma group) and 39 patients with choledochocele (control group) at the First Affiliated Hospital of Sun Yat Sen University from April 1997 to March 2007. A tissue chip containing the samples of hilar cholangiocarcinoma and choledochocele was prepared. Expressions of DNMT1, DNMT3a and DNMT3b were detected by the immunohistochemical staining. Differences in the protein expressions of DNMTs in the cholangiocarcinoma group and the control group were compared, and the correlation between DNMTs protein expressions and clinicopathological features was analyzed. All data were analyzed by using the chi square test or Fisher exact probability. The survival curve was drawn by using the Kaplan Meier method and the survival rate was compared by using the Log rank test.Results The rates of high protein expressions of DNMT1 and DNMT3b were 54.1%(60/111) and 47.7%(53/111) in the cholangio carcinoma group, which were significantly higher than 28.2%(11/39) and 23.1%(9/39) in the control group (χ2=7.740, 7.240, P<0.05). The high protein expression of DNMT1 was correlated with the Bismuth Corlette classification and T staging of the tumor (χ2=12.200, 17.800, P<0.05); there was no significant difference in the high protein expressions of DNMT3a in the cholangiocarcinoma group and the control group (χ2=3.370, P>0.05); while the high protein expressions of DNMT3b was correlated with the Bismuth Corlette classification (χ2=8.300, P<0.05), but not with the T staging. Sixty six patients received hilar cholangiocarcinoma resection, and 42 of them were followed up. The median postoperative survival time of patients with low protein expression of DNMT1 was 23.9 months, which was significantly longer than 11.8 months of patients with high protein expression of DNMT1 (χ2=3.980, P<0.05).Conclusions DNMT1 and DNMT3b with high protein expression might play important roles in the carcinogenesis and development of hilar cholangiocarcinoma. There is an obvious relationship between the expression of DNMT1 and postoperative survival time of patients with hilar cholangiocarcinoma, and DNMT1 might be a valuable prognostic factor for hilar cholangiocarcinoma.

     

/

返回文章
返回